PL2961775T3 - Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalności - Google Patents
Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalnościInfo
- Publication number
- PL2961775T3 PL2961775T3 PL14708748T PL14708748T PL2961775T3 PL 2961775 T3 PL2961775 T3 PL 2961775T3 PL 14708748 T PL14708748 T PL 14708748T PL 14708748 T PL14708748 T PL 14708748T PL 2961775 T3 PL2961775 T3 PL 2961775T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- enhanced performance
- improved processability
- processability
- improved
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361771291P | 2013-03-01 | 2013-03-01 | |
| PCT/US2014/017585 WO2014133885A1 (en) | 2013-03-01 | 2014-02-21 | Pharmaceutical compositions with enhanced performance and improved processability |
| EP14708748.0A EP2961775B1 (en) | 2013-03-01 | 2014-02-21 | Pharmaceutical compositions with enhanced performance and improved processability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2961775T3 true PL2961775T3 (pl) | 2020-11-16 |
Family
ID=50238485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14708748T PL2961775T3 (pl) | 2013-03-01 | 2014-02-21 | Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalności |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9492550B2 (pl) |
| EP (1) | EP2961775B1 (pl) |
| JP (1) | JP6456849B2 (pl) |
| KR (1) | KR102209479B1 (pl) |
| CN (1) | CN105073783B (pl) |
| BR (1) | BR112015021179B1 (pl) |
| CA (1) | CA2899546C (pl) |
| MX (1) | MX363722B (pl) |
| PL (1) | PL2961775T3 (pl) |
| RU (1) | RU2656662C2 (pl) |
| WO (1) | WO2014133885A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2961775B1 (en) * | 2013-03-01 | 2020-04-08 | Hercules LLC | Pharmaceutical compositions with enhanced performance and improved processability |
| EP3107940B1 (en) * | 2014-02-20 | 2019-08-07 | Dow Global Technologies LLC | Novel esterified cellulose ethers of high molecular weight and homogeneity |
| JP6554493B2 (ja) | 2014-06-24 | 2019-07-31 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス |
| KR20180008523A (ko) * | 2015-05-15 | 2018-01-24 | 다우 글로벌 테크놀로지스 엘엘씨 | 고분자량의 에스테르화된 셀룰로오스 에테르의 제조 방법 |
| KR20180008524A (ko) | 2015-05-15 | 2018-01-24 | 다우 글로벌 테크놀로지스 엘엘씨 | 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법 |
| JP2019504027A (ja) | 2015-12-22 | 2019-02-14 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 可溶性の生物製剤、治療薬、および造影剤を封入するためのプロセス |
| US9884922B2 (en) * | 2016-03-11 | 2018-02-06 | Shin-Etsu Chemical Co., Ltd. | Hypromellose acetate succinate, method for producing the same and composition containing the same |
| KR20190069446A (ko) * | 2016-10-18 | 2019-06-19 | 다우 글로벌 테크놀로지스 엘엘씨 | 에스터화된 셀룰로스 에터를 제조하는 효율적인 공정 |
| WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
| US12186436B2 (en) | 2018-07-19 | 2025-01-07 | The Trustees Of Princeton University | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents |
| US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226981A (en) | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
| JPS5535031A (en) | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
| JPS6281402A (ja) * | 1985-10-07 | 1987-04-14 | Shin Etsu Chem Co Ltd | セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法 |
| JP3149122B2 (ja) | 1994-11-07 | 2001-03-26 | 信越化学工業株式会社 | 固形腸溶製剤のコーティング用基剤 |
| PT901786E (pt) | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Disperções farmacêuticas sólidas com biodisponibilidade melhorada |
| ES2306646T3 (es) | 1999-02-09 | 2008-11-16 | Pfizer Products Inc. | Composiciones de farmacos basicos con biodisponibilidad incrementada. |
| EP1738749A1 (en) | 1999-12-23 | 2007-01-03 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
| US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| JP2008501009A (ja) * | 2004-05-28 | 2008-01-17 | ファイザー・プロダクツ・インク | 性能を高めた医薬組成物 |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| US8133513B2 (en) | 2006-03-23 | 2012-03-13 | Shionogi & Co., Ltd. | Solid preparation having improved solubility |
| EP2155166A2 (en) | 2007-05-11 | 2010-02-24 | F. Hoffmann-Roche AG | Pharmaceutical compositions for poorly soluble drugs |
| CA2801712A1 (en) | 2010-06-14 | 2011-12-22 | Dow Global Technologies Llc | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| JP2015512456A (ja) | 2012-03-27 | 2015-04-27 | ダウ グローバル テクノロジーズ エルエルシー | セルロースエーテルのエステルの製造方法 |
| JP6133969B2 (ja) | 2012-04-11 | 2017-05-24 | ダウ グローバル テクノロジーズ エルエルシー | 特定の置換基分布を有するエステル化セルロースエーテル |
| EP2961775B1 (en) * | 2013-03-01 | 2020-04-08 | Hercules LLC | Pharmaceutical compositions with enhanced performance and improved processability |
-
2014
- 2014-02-21 EP EP14708748.0A patent/EP2961775B1/en active Active
- 2014-02-21 BR BR112015021179-8A patent/BR112015021179B1/pt active IP Right Grant
- 2014-02-21 PL PL14708748T patent/PL2961775T3/pl unknown
- 2014-02-21 CN CN201480011462.1A patent/CN105073783B/zh active Active
- 2014-02-21 WO PCT/US2014/017585 patent/WO2014133885A1/en active Application Filing
- 2014-02-21 JP JP2015560226A patent/JP6456849B2/ja active Active
- 2014-02-21 KR KR1020157023293A patent/KR102209479B1/ko active Active
- 2014-02-21 MX MX2015010398A patent/MX363722B/es active IP Right Grant
- 2014-02-21 CA CA2899546A patent/CA2899546C/en active Active
- 2014-02-21 US US14/186,147 patent/US9492550B2/en active Active
- 2014-02-21 RU RU2015141521A patent/RU2656662C2/ru active
-
2016
- 2016-07-22 US US15/216,936 patent/US10106625B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2899546C (en) | 2017-10-10 |
| RU2015141521A (ru) | 2017-04-06 |
| CN105073783A (zh) | 2015-11-18 |
| EP2961775A1 (en) | 2016-01-06 |
| JP6456849B2 (ja) | 2019-01-23 |
| US20140249235A1 (en) | 2014-09-04 |
| KR102209479B1 (ko) | 2021-02-01 |
| WO2014133885A1 (en) | 2014-09-04 |
| MX363722B (es) | 2019-03-29 |
| CA2899546A1 (en) | 2014-09-04 |
| MX2015010398A (es) | 2015-10-29 |
| EP2961775B1 (en) | 2020-04-08 |
| KR20150125655A (ko) | 2015-11-09 |
| RU2656662C2 (ru) | 2018-06-06 |
| US9492550B2 (en) | 2016-11-15 |
| CN105073783B (zh) | 2018-04-03 |
| BR112015021179A2 (pt) | 2017-07-18 |
| US10106625B2 (en) | 2018-10-23 |
| BR112015021179B1 (pt) | 2021-11-30 |
| JP2016510080A (ja) | 2016-04-04 |
| US20160376380A1 (en) | 2016-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273205A (en) | Preparations and methods | |
| IL244850A0 (en) | Stabilized epinaconazole preparations, and their uses | |
| IL244877A0 (en) | Compounds and composites for high performance | |
| HK1218837A1 (zh) | 組合物和方法 | |
| HK1218560A1 (zh) | 組成與方法 | |
| GB2520795B (en) | Compositions and methods | |
| HK1215595A1 (zh) | 白細胞介素- 藥物組合物和使用方法 | |
| GB2518288B (en) | Fuel compositions | |
| SMT201900339T1 (it) | Coniugati anticorpo anti-dll3/pbd e loro usi | |
| ZA201604585B (en) | Multistage polymers and compositions thereof | |
| ZA201505966B (en) | Peptides and compositions | |
| PL2961775T3 (pl) | Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalności | |
| GB201308072D0 (en) | Compositions and methods | |
| HK1220920A1 (zh) | 治療性組合物和其用途 | |
| GB201321693D0 (en) | Composition and uses thereof | |
| EP2992334A4 (en) | Novel phosphatidylalkanols and compositions thereof | |
| IL276126B (en) | Preparations containing l-4-chloroquinonerine and their uses | |
| GB201305813D0 (en) | Compositions and methods | |
| EP3007720A4 (en) | COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF | |
| HK1219691A1 (zh) | 醫藥組成物及其用途 | |
| EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
| GB201308242D0 (en) | Compositions and uses thereof | |
| GB201301022D0 (en) | Composition and uses thereof | |
| GB201322617D0 (en) | Methods and compositions | |
| GB201312393D0 (en) | Compositions and Methods |